End results of surgical treatment in unknown primary vertebral metastases malignancy

Research Article

American Journal of BioMedicine
Volume 11, Issue 1, 28 February 2023, Pages 45-56 | http://dx.doi.org/10.18081/2333-5106/2023.11/45

José D. W., Monika E. Or, Fadel Guen 1*  

Received  23 August  2022   Revised  12 November 2022   Accepted  23 January 2023   Published  28 February 2023



Spinal metastases are the most common type of bone metastases and currently, external radiation and steroid therapy are used in most patients with neoplastic spinal cord compression. Surgery is generally used to treat those who do not respond to radiation therapy. The objective of this study is to analyze different types of surgical access in the treatment of patients with metastatic vertebral lesions. Selected adequate surgical resection access for 83 patients’ with spinal metastasis enrolled in this study, the surgery depended on tumor site, nerve structures and operation access that used to resect tumors: anterior, posteriorly, lateral and posterolateral access. Inconclusion, selection surgical treatment for spinal metastases is mainly to relieve pain, rebuild spinal stability, improve nerve function, control local tumors, and improve the quality of life of patients.

Keywords: Spinal metastases; Cancer; Surgery, Radiation therapy

Copyright © 2023 Fadel Guen, et al. This article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cited by other articlesReferencesDownload this articleStatistics
The citation data is computed by the following citation measuring services:

  1. 1. Barzilai O, Laufer I, Yamada Y, et al Integrating evidence‐based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease. J Clin Oncol 2017; 35:2419-2427.
    2. Hillen HFP. Unknown primary tumours. Postgrad Med J 2000; 76:690-693.
    3. Barzilai O, McLaughlin L, Amato MK, et al Predictors of quality-of-life improvement after surgery for metastatic tumors of the spine: prospective cohort study. Spine J 2018; 18:1109-1115.
    4. National Collaborating Centre for Cancer. Metastatic malignant disease of unknown primary origin-diagnosis and management of metastatic malignant disease of unknown primary origin. In: NICE Clinical Guideline 2010; 104, pp 1-38.
    5. Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus 2001; 11:e10.
    6. Yamashita T, Siemionow KB, Mroz TE, Podichetty V, Lieberman IH. A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised Tokuhashi score. Spine (Phila Pa 1976) 2011; 36:910-917.
    7. Moussazadeh N, Laufer I, Yamada Y, Bilsky MH. Separation surgery for spinal metastases: effect of spinal radiosurgery on surgical treatment goals. Cancer Control 2014; 21:168-174.
    8. North RB, LaRocca VR, Schwartz J, et al. Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J Neurosurg: Spine. 2005; 2:564-573.
    9. Rades D, Abrahm JL. The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol 2010; 7:590-598.
    10. Witham TF, Khavkin YA, Gallia GL, Wolinsky JP, Gokaslan ZL. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2006; 2:87-94.
    11. Yang SB, Cho W, Chang UK. Analysis of prognostic factors relating to postoperative survival in spinal metastases. J Korean Neurosurg Soc 2009; 51:127-134.
    12. Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D. Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer 2012; 12:261.
    13. Yao A, Sarkiss CA, Ladner TR, Jenkins AL 3rd. Contemporary spinal oncology treatment paradigms and outcomes for metastatic tumors to the spine: a systematic review of breast, prostate, renal, and lung metastases. J Clin Neurosci 2017; 41:11-23.
    14. Oka S, Matsumiya H, Shinohara S, et al Total or partial vertebrectomy for lung cancer invading the spine. Ann Med Surg (Lond) 2016; 12:1-4.
    15. Rades D, Fehlauer F, Veninga T, et al. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Int J Radiat Oncol Biol Phys 2007; 167:532-537.
    16. Daniel JW, Veiga JC. Prognostic parameters and spinal metastases: a research study. PLoS One 2014; 9:e109579.
    17. Péus D, Newcomb N, Hofer S. Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak 2013; 13:72.
    18. Rades D, Huttenlocher S, Bajrovic A, et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavourable tumours. Int J Radiat Oncol Biol Phys 2011; 81:861-868.
    19. Masuda K, Ebata K, Yasuhara Y, Enomoto A, Saito T. Outcomes and prognosis of neurological decompression and stabilization for spinal metastasis is assessment with the spinal instability neoplastic score useful for predicting surgical results. Asian Spine J 2018; 12:846-853.
    20. Quraishi NA, Rajagopal TS, Manoharan SR, Elsayed S, Edwards KL, Boszczyk BM. Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression. Eur Spine J 2013; 22:1383-1388.
    21. Cazzato RL, Garnon J, Caudrelier J, Rao PP, Koch G, Gangi A. Percutaneous radiofrequency ablation of painful spinal metastasis: a systematic literature assessment of analgesia and safety. Int J Hyperthermia 2018; 34:1272-1281.
    22. Patchell RA, Tibbs PA, Regine WF, et al Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005; 366:643-648.
    23. Gasbarrini A, Li H, Cappuccio M, Mirabile L, Paderni S, et al. Efficacy evaluation of a new treatment algorithm for spinal metastases. Spine (Phila Pa 1976) 2009; 35:1466-1470.
    24. Pointillart V, Vital JM, Salmi R, et al. Survival prognostic factors and clinical outcomes in patients with spinal metastases. J Cancer Res Clin Oncol 2011; 137(5):849-856.
    25. Lei M, Liu Y, Tang C, et al. Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer 2015; 15:853.
    26. Iizuka Y, Iizuka H, Tsutsmi S, Nakagawa Y, Nakajima T, et al. Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT- guided biopsy. Eur Spine J 2009; 18:1431-1435.
    27. Quraishi NA, Gokaslan ZL, Boriani S. The surgical management of metastatic epidural compression of the spinal cord. J Bone Joint Surg Br 2010; 92:1054-1060.
    28. Leithner A, Radl R, Gruber G, et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 2008; 17(11):1488-1495.
    29. Oliveira MF, Barros BA, Rotta JM, Botelho RV. Tokuhashi Scoring System has limited applicability in the majority of patients with spinal cord compression secondary to vertebral metastasis. Arq Neuropsiquiatr 2013; 71:798-801.
    30. Goodwin CR, Sankey EW, Liu A, et al A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases. J Neurosurg Spine 2015; 24:837-849.
    31. Aizenberg MR, Fox BD, Suki D, McCutcheon IE, Rao G, et al. Surgical management of unknown primary tumors metastatic to the spine: clinical article. J Neurosurg Spine 2012; 16:86-92.
    32. Tokuhashi Y, Ajiro Y, Umezawa N. Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine (Phila Pa 1976) 2009; 34:69-73.
    33. Murakami H, Kawahara N, Demura S, Kato S, Yoshioka K, Tomita K. Total en bloc spondylectomy for lung cancer metastasis to the spine. J Neurosurg Spine 2010; 13:414-417.
    34. Pennington Z, Ahmed AK, Molina CA, Ehresman J, Laufer I, Sciubba DM. Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence. Ann Transl Med 2018; 6:103.
    35. Bollen L, van der Linden YM, Pondaag W, et al Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients. Neuro Oncol 2014; 16:991-998.

1. Access through OpenAthens

2. PDF     XML

For any technique error please contact us.


      PDF           XML

How to cite this article

Aruna D, Adereti A, Munir EA. Prevalence of hepatitis C virus infection among hemodialysis patients: cohort study. American Journal of BioMedicine 2023; 11(1):36-44.

More Citation Formats

Chandra, S., and Vijayakumar, V. (2023). Laparoscopic ovarian electrocauterization in polycystic ovarian syndrome: outcome and Influencing factors. American Journal of BioMedicine, 11(1), 10-21.doi: 10.18081/2333-5106/2023.11/10
Sambit Chandra; Sujeet D. Vijayakumar. “Laparoscopic ovarian electrocauterization in polycystic ovarian syndrome: outcome and Influencing factors”. American Journal of BioMedicine, 11, 1, 2023, 10-21. doi: 10.18081/2333-5106/2023.11/10
Chandra, S., Vijayakumar, V. (2023). Laparoscopic ovarian electrocauterization in polycystic ovarian syndrome: outcome and Influencing factors. American Journal of BioMedicine, 11(1), PP. 10-21.doi: 10.18081/2333-5106/2023.11/10
Chandra, S., Vijayakumar, V. Laparoscopic ovarian electrocauterization in polycystic ovarian syndrome: outcome and Influencing factors. American Journal of BioMedicine, 2023; 11(1):10-21.doi: 10.18081/2333-5106/2023.11/10

Article metric

Rights and permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles published in American Journal of BioMedicine  are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.